Source:http://linkedlifedata.com/resource/pubmed/id/13229519
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1955-12-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/BLOOD/diseases,
http://linkedlifedata.com/resource/pubmed/keyword/BONE MARROW/diseases,
http://linkedlifedata.com/resource/pubmed/keyword/LYMPHATIC SYSTEM/diseases,
http://linkedlifedata.com/resource/pubmed/keyword/TRIETHYLENE MELAMINE/therapeutic use
|
pubmed:language |
ita
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
OLDMEDLINE
|
pubmed:issn |
0004-0193
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1179-250
|
pubmed:dateRevised |
2008-6-3
|
pubmed:meshHeading | |
pubmed:articleTitle |
[Triethylene-melamine and its combinations in therapy of hemolymphoblastosis].
|
pubmed:publicationType |
Journal Article
|